Literature DB >> 6113921

Mesenteric vascular reactivity to histamine receptor agonists and antagonists.

K M Walus, J D Fondacaro, E D Jacobson.   

Abstract

Response patterns of intestinal blood flow, oxygen extraction and consumption, blood flow distribution, and motility were assessed during intraarterial infusions of histamine, histamine after H1 or H2 blockade, dimaprit or dimaprit after H2 blockade. Histamine produced an initial peak response of blood flow with a slow decrease thereafter. Oxygen extraction was evenly depressed throughout the infusion, and oxygen consumption increased at the beginning. All initial responses were blocked by tripelennamine. Ranitidine, a new H2 antagonist, accelerated the decay of all responses. Dimaprit produced effects identical to those of histamine after tripelennamine. Distribution of blood flow was unchanged at the beginning of histamine infusion, but subsequently showed a shift to muscularis which was blocked by tripelennamine. Histamine usually stimulated intestinal contractions and this effect was abolished by tripelennamine. Thus, H1 stimulation, besides producing an initial vasodilation, increases oxygen uptake and redistributes flow to the muscularis.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6113921     DOI: 10.1007/bf01313587

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  18 in total

1.  Tissue blood flow and distribution of cardiac output in cats: changes caused by intravenous infusions of histamine and histamine receptor agonists.

Authors:  B M Johnston; D A Owen
Journal:  Br J Pharmacol       Date:  1977-06       Impact factor: 8.739

Review 2.  Peripheral vascular H2 receptors to histamine.

Authors:  M Schwaiger; E D Jacobson
Journal:  Circ Shock       Date:  1979

3.  Effects of glucagon, histamine, and perhexiline on the ischemic canine mesenteric circulation.

Authors:  M Schwaiger; J D Fondacaro; E D Jacobson
Journal:  Gastroenterology       Date:  1979-10       Impact factor: 22.682

4.  Definition and antagonism of histamine H 2 -receptors.

Authors:  J W Black; W A Duncan; C J Durant; C R Ganellin; E M Parsons
Journal:  Nature       Date:  1972-04-21       Impact factor: 49.962

5.  Receptors mediating some actions of histamine.

Authors:  A S Ash; H O Schild
Journal:  Br J Pharmacol Chemother       Date:  1966-08

6.  Ranitidine (AH 19065): a new potent, selective histamine H2-receptor antagonist [proceedings].

Authors:  J Bradshaw; R T Brittain; J W Clitherow; M J Daly; D Jack; B J Price; R Stables
Journal:  Br J Pharmacol       Date:  1979-07       Impact factor: 8.739

7.  The effect of vasoactive substances on the circulation and glucose absorption of an isolated jejunal loop in the dog.

Authors:  V Varró; I Jung; F Szarvas; L Csernay; G Sávay; J Okrös
Journal:  Am J Dig Dis       Date:  1967-01

8.  Drug-induced changes in capillary filtration coefficient and blood flow in the innervated small intestine of the anaesthetized cat.

Authors:  P D Richardson
Journal:  Br J Pharmacol       Date:  1974-12       Impact factor: 8.739

9.  Motility and blood flow distribution within the wall of the gastrointestinal tract.

Authors:  C C Chou; B Grassmick
Journal:  Am J Physiol       Date:  1978-07

10.  A solid-state arteriovenous oxygen difference analyzer for flowing whole blood.

Authors:  A P Shepherd; C G Burgar
Journal:  Am J Physiol       Date:  1977-04
View more
  3 in total

1.  Increased colonic mucosal mast cells associated with severe watery diarrhea and microscopic colitis.

Authors:  C A Baum; P Bhatia; P B Miner
Journal:  Dig Dis Sci       Date:  1989-09       Impact factor: 3.199

Review 2.  An update on histamine receptors and the gastrointestinal tract.

Authors:  B I Hirschowitz
Journal:  Dig Dis Sci       Date:  1985-10       Impact factor: 3.199

Review 3.  Penile cancer.

Authors:  Anita Thomas; Andrea Necchi; Asif Muneer; Marcos Tobias-Machado; Anna Thi Huyen Tran; Anne-Sophie Van Rompuy; Philippe E Spiess; Maarten Albersen
Journal:  Nat Rev Dis Primers       Date:  2021-02-11       Impact factor: 52.329

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.